Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics ; volume:17 ; number:1 ; day:2 ; month:2 ; year:2017 ; pages:1-10 ; date:12.2017
BMC public health ; 17, Heft 1 (2.2.2017), 1-10, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Sanderson, Maureen
- Contributor
-
Canedo, Juan R.
Khabele, Dineo
Fadden, Mary K.
Harris, Cynthia
Beard, Katina
Burress, Marilyn
Pinkerton, Helen
Jackson, Cynthia
Mayo-Gamble, Tilicia
Hargreaves, Margaret K.
Hull, Pamela C.
SpringerLink (Online service)
- DOI
-
10.1186/s12889-017-4094-1
- URN
-
urn:nbn:de:1111-2017022611384
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sanderson, Maureen
- Canedo, Juan R.
- Khabele, Dineo
- Fadden, Mary K.
- Harris, Cynthia
- Beard, Katina
- Burress, Marilyn
- Pinkerton, Helen
- Jackson, Cynthia
- Mayo-Gamble, Tilicia
- Hargreaves, Margaret K.
- Hull, Pamela C.
- SpringerLink (Online service)
Other Objects (12)
Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics
Primary care clinicians’ perspectives about quality measurements in safety-net clinics and non-safety-net clinics
Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics
Cost-effectiveness of human papillomavirus vaccination in Germany
Modelling vaccination capacity at mass vaccination hubs and general practice clinics: a simulation study
Myasthenia gravis following human papillomavirus vaccination: a case report
Human Papillomavirus (HPV) Vaccination in Nigeria: Is It Equitable?
Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme
Human papillomavirus vaccination for adult women : Number 6 - June 2022
Exploring reasons for non-vaccination against human papillomavirus in Italy
Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination
Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?
Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics
Primary care clinicians’ perspectives about quality measurements in safety-net clinics and non-safety-net clinics
Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics
Cost-effectiveness of human papillomavirus vaccination in Germany
Modelling vaccination capacity at mass vaccination hubs and general practice clinics: a simulation study
Myasthenia gravis following human papillomavirus vaccination: a case report
Human Papillomavirus (HPV) Vaccination in Nigeria: Is It Equitable?
Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme
Human papillomavirus vaccination for adult women : Number 6 - June 2022
Exploring reasons for non-vaccination against human papillomavirus in Italy
Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination
Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?
Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics
Primary care clinicians’ perspectives about quality measurements in safety-net clinics and non-safety-net clinics
Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics
Cost-effectiveness of human papillomavirus vaccination in Germany
Modelling vaccination capacity at mass vaccination hubs and general practice clinics: a simulation study
Myasthenia gravis following human papillomavirus vaccination: a case report
Human Papillomavirus (HPV) Vaccination in Nigeria: Is It Equitable?
Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme
Human papillomavirus vaccination for adult women : Number 6 - June 2022
Exploring reasons for non-vaccination against human papillomavirus in Italy
Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination